the Synergistic Compatibility Framework
  • Home
  • What's Inside the Framework
  • SCF Developments
  • SCF Publications
  • SCF Systems Therapeutic’s AI Ecosystem
  • SCF ADVANCED MEDICINE RESEARCH
the Synergistic Compatibility Framework

About the Company

Contact

Regulatory Disclaimer

Terms of Use

SCF MULTI-OMIC GENE NETWORK MODELING OF SEIZURE THRESHOLDS | ANTI-TRAUMATIC GRAN MAL SEIZURES (GTCS)

Model Code: SCF-MOGN-ST-EPI-GMS-0001

Classification: Systems Biology + Multi-Omics Threshold Dynamics Modeling Framework

I. SCOPE & OBJECTIVE

To construct a quantitative, multi-omic gene-network model that defines:

  • The biological seizure threshold (ST) as a dynamic systems variable
  • The transition from subthreshold → ictal state
  • The multi-layer gene-network interactions driving threshold collapse

Goal:

Enable predictive, personalized, and intervention-guided control of seizure onset.

II. SCF SEIZURE THRESHOLD (ST) — SYSTEM DEFINITION

Conceptual Definition

The seizure threshold is a network equilibrium state governed by:

  • Excitatory vs inhibitory gene activity
  • Neuroimmune load
  • Bioenergetic capacity
  • Network synchronization

SCF Threshold Equation (Systems Model)

ST=(Ginh+EATP+Sstability)(Gexc+Iinf+Nsync)ST = \frac{(G_{inh} + E_{ATP} + S_{stability})}{(G_{exc} + I_{inf} + N_{sync})}ST=(Gexc​+Iinf​+Nsync​)(Ginh​+EATP​+Sstability​)​

Variable
Meaning
GinhG_{inh}Ginh​
Inhibitory gene network activity (GABAergic)
EATPE_{ATP}EATP​
Bioenergetic capacity
SstabilityS_{stability}Sstability​
Network resilience
GexcG_{exc}Gexc​
Excitatory gene activity
IinfI_{inf}Iinf​
Inflammatory signaling
NsyncN_{sync}Nsync​
Network synchronization pressure

III. CORE GENE NETWORK MODULES

3.1 Excitatory Network (Pro-Seizure Module)

Gene Cluster
Function
GRIN1, GRIN2B
NMDA receptor signaling
GRIA1
AMPA receptor activation
SCN8A, SCN2A
Sodium channel excitability

Output: ↑ Depolarization, ↓ threshold

3.2 Inhibitory Network (Protective Module)

Gene Cluster
Function
GABRA1, GABRB3
GABA-A receptor
GAD1, GAD2
GABA synthesis
SLC6A1
GABA transport

Output: ↑ Threshold stabilization

3.3 Neuroimmune Network

Gene Cluster
Function
IL1B, TNF
Cytokine signaling
NFKB1
Inflammatory transcription
TLR4
Damage sensing

Output: Lowers threshold via synaptic modulation

3.4 Bioenergetic Network

Gene Cluster
Function
PPARGC1A
Mitochondrial biogenesis
ATP5F1A
ATP synthesis
SOD2
ROS detox

Output: Maintains neuronal stability

3.5 Plasticity & Network Remodeling

Gene Cluster
Function
BDNF, CREB1
Synaptic strengthening
ARC
Activity-dependent remodeling

Output: Reinforces epileptogenic circuits

3.6 Epigenetic Control Network

Gene Cluster
Function
DNMT1, DNMT3A
DNA methylation
HDAC1, HDAC2
Chromatin repression
MECP2
Gene silencing

Output: Fixes low-threshold state

IV. MULTI-OMIC INTEGRATION LAYERS

Omics Layer
Network Contribution
Genomics
Baseline susceptibility
Transcriptomics
Dynamic gene activation
Proteomics
Functional receptor expression
Metabolomics
Energy availability
Epigenomics
Long-term threshold shifts
Connectomics
Network synchronization

V. NETWORK INTERACTION MATRIX

Module
Interacts With
Effect
Excitatory
Inhibitory
Balance determines ST
Immune
Excitatory
Amplifies firing
Metabolic
All
Supports stability
Epigenetic
All
Locks system state

VI. THRESHOLD STATES (SCF CLASSIFICATION)

State
ST Value
Description
Stable
High
No seizure risk
Primed
Moderate
Vulnerable
Critical
Low
Pre-ictal
Collapsed
Zero
Seizure onset

VII. DYNAMIC THRESHOLD TRAJECTORY

Temporal Progression

Stable

→ Immune activation

→ Excitatory dominance

→ Energy depletion

→ Epigenetic fixation

→ Threshold collapse → Seizure

VIII. NETWORK PERTURBATION ANALYSIS

8.1 High-Risk Perturbations

  • ↑ GRIN2B + ↓ GABRA1
  • ↑ IL1B + ↑ TNF
  • ↓ ATP + ↑ ROS

8.2 Protective Configurations

  • ↑ GABA gene expression
  • ↑ mitochondrial efficiency
  • ↓ inflammatory signaling

IX. SCF MULTI-OMIC PREDICTIVE MODEL

9.1 Input Variables

  • Gene expression profiles
  • Biomarker panels
  • EEG synchronization metrics

9.2 Output

  • Seizure probability score
  • Time-to-threshold collapse
  • Dominant pathogenic pathway

X. PERSONALIZED SCF THRESHOLD PROFILING

Patient Type
Dominant Driver
Strategy
Genetic
Ion channel genes
Channel modulators
Traumatic
Inflammation
Anti-inflammatory
Metabolic
ATP deficiency
Mitochondrial therapy
Mixed
Multi-system
SCF combination therapy

XI. THERAPEUTIC NETWORK TARGETING

Network
Intervention
Excitatory
NMDA antagonists
Inhibitory
GABA enhancers
Immune
NF-κB inhibitors
Metabolic
NAD⁺ boosters
Epigenetic
HDAC/DNMT modulators

XII. SCF ADVANCED ANALYTICS

12.1 Network Topology Mapping

  • Identify hub genes (SCN1A, GRIN2B, IL1B)
  • Target hubs for maximum effect

12.2 Feedback Loop Modeling

  • Positive loops: excitatory + inflammation
  • Negative loops: inhibitory stabilization

12.3 Digital Twin Simulation

  • Simulate threshold changes under therapy
  • Predict optimal intervention timing

XIII. NEXT STRATEGIC RESEARCH PATHWAYS

  1. AI-driven gene network modeling of seizure thresholds
  2. Real-time integration with wearable EEG + biomarkers
  3. CRISPR modulation of network hub genes
  4. Dynamic epigenetic editing to restore threshold
  5. Closed-loop drug delivery based on threshold prediction

MASTER REGISTRY INDEX

  • SCF-MOGN-ST-EPI-GMS-0001 — Multi-Omic Gene Network Threshold Model
  • SCF-CT-PTM-EPI-GMS-TRM-0001 — Pseudotime Mapping Atlas
  • SCF-MMST-CYTO-EPI-GMS-TRM-0001 — Spatiotemporal Cytogenesis Atlas
  • SCF-PGGL-EPI-CORE-0003 — Gene Mapping Atlas
  • SCF-MNSMA-EPI-GMS-0001 — Multi-Neurosystems Atlas
  • SCF-PATH-EXT-0001 — SCF Pathophysiology Protocol
  • SCF-SEF-MD-0001 — Synergistic Evaluation Framework